Brief news reports on Tuberculosis

Advocacy webinar to prioritize TB in 2019 PEPFAR COPs

Back by popular demand! As tuberculosis (TB) is the leading global killer of people living with HIV, TB programming must be prioritized and integrated within life-saving bilateral efforts such as PEPFAR. The expected release of the PEPFAR Country Operational Plans (COPs) provides a critical opportunity for advocates to ensure that the latest developments in TB treatment, prevention and diagnostics are implemented within PEPFAR countries.

Read More →

Vacancy: Project Manager for Out of Step report

The Stop TB Partnership and Médecins Sans Frontières are seeking a candidate to coordinate and lead work on the Out of Step 2020 report.

Read More →

Global Fund announces US$14 billion target to step up the fight against AIDS, TB and malaria ahead of Lyon Conference in October 2019

PARIS, 11 January 2019 – The Global Fund today announced its fundraising target for the next three-year cycle, outlining how a minimum of US$14 billion will help save 16 million lives, cut the mortality rate from HIV, TB and malaria in half, and build stronger health systems by 2023. The summary of the Sixth Replenishment Investment Case describes what can be achieved by a fully funded Global Fund, the new threats facing global health progress today, and the risks if we don’t step up the fight now.

Read More →

December edition of the Stop TB Partnership's newsletter

The Stop TB Partnership released its December newsletter, presenting the initiatives and activities carried out during the month. It also contains information about upcoming events.

Read More →

Study sheds more light on delamanid role in treating MDR-TB

A phase 3 trial of delamanid, a newer oral drug for treating multidrug-resistant tuberculosis (MDR-TB), found no statistically significant reduction in time to sputum culture conversion when compared to placebo, but that it was safe and well tolerated.

Read More →

TB detection may be affected by blood draw method

Healthcare workers participating in annual tuberculosis screening had differences in interferon (IFN)-γ level depending on blood draw methods, according to study results published in the Annals of the American Thoracic Society.

Read More →

Issue brief: Backing Civil Society to End the AIDS, Tuberculosis and Malaria Epidemics

January 9, 2019 — Friends of the Global Fight is releasing an issue brief today, “Backing Civil Society to End the AIDS, Tuberculosis and Malaria Epidemics.” This issue brief highlights the pivotal role in the fight against HIV/AIDS, tuberculosis and malaria played by civil society—all those stakeholders who are neither government bodies nor private sector enterprises, such as NGOs, advocacy groups and faith based organizations.

Read More →

Deep learning algorithm outperforms physicians detecting active pulmonary TB

A deep-learning algorithm performed better than radiologists at detecting active pulmonary tuberculosis (TB) on chest radiographs, according to data published in Clinical Infectious Diseases.

Read More →

Researchers develop new TB treatment

Led by researchers at RCSI (Royal College of Surgeons in Ireland), a team of researchers has developed a new treatment for tuberculosis (TB). This work could offer a practical treatment that has the potential to be scaled-up and mass-produced for clinical testing.

Read More →

The evolution of TB treatment in India

"... the need of the hour is to expand access to treatment for the most vulnerable subset of multidrug-resistant TB patients and ensure the judicious use of antibiotics in the public and private sector, while maintaining the level of funding required to tackle the growing threat of drug-resistant TB."

Read More →

Page 2 of 626 · Total posts: 10

←First 1 2 3 Last→